Status:
COMPLETED
Neutrophil Gelatinase-associated Lipocalin Concentration in Coronary Artery Disease
Lead Sponsor:
Cardiovascular Research Society, Greece
Conditions:
Coronary Artery Disease
Atherosclerosis
Eligibility:
All Genders
18-85 years
Brief Summary
Serum NGAL has been described as a biomarker of neutrophil activation and an inflammatory marker which correlates to obesity and its metabolic complications. Since neutrophil activation has been impli...
Detailed Description
Inflammation is considered to play a major role in coronary artery disease (CAD) which accounts for high morbidity and mortality rates in the western world. Several lines of evidence support a role fo...
Eligibility Criteria
Inclusion
- Consenting patients undergoing coronary angiography due to suspected CAD based on clinical history and results from non-invasive testing
Exclusion
- Abnormal renal function
- Any known active inflammatory disease
- Receiving medical therapy with antibiotics, corticosteroids, immunosuppressive agents
Key Trial Info
Start Date :
September 1 2008
Trial Type :
OBSERVATIONAL
Allocation :
ACTUAL
End Date :
September 1 2009
Estimated Enrollment :
73 Patients enrolled
Trial Details
Trial ID
NCT00749281
Start Date
September 1 2008
End Date
September 1 2009
Last Update
July 8 2010
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Athens Euroclinic
Athens, Attica, Greece, 11521